The profits lie in treating later-stage cancers; a study shows it’s because of the incentives in the interplay between the patent system and the F.D.A. approval process.
The New Health Care: Why Preventing Cancer Is Not the Priority in Drug Development
ByAUSTIN FRAKT
Dec 28, 2015